Your search found 154 Results
High-risk human papillomavirus infection in the prediction of poor treatment response and disease recurrence in patients with vulvovaginal condyloma.
International Journal of Gynaecology and Obstetrics. 2016 Jan; 132(1):20-4.Add to my documents.
Important considerations in adolescent health maintenance: long-acting reversible contraception, human papillomavirus vaccination, and heavy menstrual bleeding.
Current Opinion In Pediatrics. 2016 Sep 26;Add to my documents.
Factors related to non-compliance to HPV vaccination in Roraima-Brazil: a region with a high incidence of cervical cancer.
BMC Health Services Research. 2016 Aug 22; 16(417):1-9.Add to my documents.
Advanced Drug Delivery Reviews. 2015 Sep 15; 92:27-38.Add to my documents.
Treatment and Follow-up of Human Papillomavirus Infected Women in a Municipality in Southern Brazil.
Asian Pacific Journal of Cancer Prevention. 2015; 16(15):6521-6.Add to my documents.
Annals of Medicine. 2016 May; 48(3):149-161.Add to my documents.
Frontiers in Oncology. 2015 Nov; 5:Article 239.Add to my documents.
[Geneva, Switzerland], WHO, 2015 Dec 17.  p.Add to my documents.
[London, United Kingdom], Cervical Cancer Action, 2015.  p.Add to my documents.
Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia.
BMC Public Health. 2016 Jan 23; 16(71):1-5.Add to my documents.
Results of a health education message intervention on HPV knowledge and receipt of follow–up care among Latinas infected with high–risk human papillomavirus.
Journal of Health Care for the Poor and Underserved. 2015 Nov; 26(4):1440-1455.Add to my documents.
Prevalence and clinical manifestations of male patients with anogenital warts attending a sexually transmitted disease clinic prior HPV vaccine recommentation.
Southeast Asian Journal of Tropical Medicine and Public Health. 2014 Nov; 45(6):1337-43.Add to my documents.
Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy.
Infectious Agents and Cancer. 2015; 10:17.Add to my documents.
Annals of Surgical Oncology. 2015 Mar; 22(3):728-33.Add to my documents.
African Journal of Reproductive Health. 2015 Mar; 19(1):9-13.Add to my documents.
European Journal of Gynaecological Oncology. 2015; 36(3):252-4.Add to my documents.
Washington, D.C., PATH, 2015 Jun.  p. (Advocacy Impact Case Studies)Add to my documents.
International Journal of Dermatology. 2014 Nov; 53(11):e486-91.Add to my documents.
PloS One. 2014; 9(10):e109353.Add to my documents.
[Efficacy of commercially available vaccines against HPV infection in women: a systematic review and meta-analysis] Eficacia das vacinas comercialmente disponiveis contra a infeccao pelo papilomavirus em mulheres: revisao sistematica e metanalise.
Cadernos De Saude Publica. 2013 Nov; 29 Suppl 1:S32-44.Add to my documents.
New England Journal of Medicine. 2015 Feb 19; 372(8):711-723.Add to my documents.
The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
International Journal of Cancer. 2015; ( p)Add to my documents.
Geneva, Switzerland, WHO, 2014.  p.Add to my documents.
Trends in Microbiology. 2015;  p.Add to my documents.
MMWR. Morbidity and Mortality Weekly Report. 2015 Feb 20; New Delhi, India, WHO, Regional Office for South-East Asia, 2015. 64(6):137-140.  p.Add to my documents.